Cosmos Health (COSM) | Financial Analysis & Statements
Cosmos Health Inc. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
19.7M
Gross Profit
2.1M
10.55%
Operating Income
-11.2M
-57.07%
Net Income
-10.1M
-51.49%
Balance Sheet Metrics
Total Assets
65.5M
Total Liabilities
47.1M
Shareholders Equity
18.4M
Debt to Equity
2.55
Cash Flow Metrics
Operating Cash Flow
-8.5M
Free Cash Flow
-4.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Cosmos Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 65.3M | 54.4M | 53.4M | 50.3M | 56.2M |
| Cost of Goods Sold | 57.4M | 50.1M | 49.0M | 44.4M | 47.9M |
| Gross Profit | 7.9M | 4.3M | 4.3M | 6.0M | 8.3M |
| Gross Margin % | 12.1% | 7.9% | 8.1% | 11.8% | 14.8% |
| Operating Expenses | |||||
| Research & Development | 519.4K | 533.3K | - | - | - |
| Selling, General & Administrative | 22.5M | 17.8M | 25.6M | 13.2M | 12.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 23.1M | 18.3M | 25.6M | 13.2M | 12.4M |
| Operating Income | -16.5M | -15.3M | -21.8M | -7.5M | -4.5M |
| Operating Margin % | -25.3% | -28.0% | -40.9% | -14.8% | -8.1% |
| Non-Operating Items | |||||
| Interest Income | 396.4K | 406.4K | 662.9K | 236.3K | 46.3K |
| Interest Expense | 2.6M | 1.0M | 866.5K | 4.0M | 3.6M |
| Other Non-Operating Income | -378.0K | -324.3K | 3.5M | -1.9M | 220.3K |
| Pre-tax Income | -19.1M | -16.2M | -18.5M | -13.1M | -7.8M |
| Income Tax | 0 | 0 | 0 | 775.1K | 114.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -19.1M | -16.2M | -18.5M | -13.8M | -8.0M |
| Net Margin % | -29.3% | -29.7% | -34.7% | -27.5% | -14.2% |
| Key Metrics | |||||
| EBITDA | -16.9M | -13.5M | -20.6M | -9.5M | -4.1M |
| EPS (Basic) | - | $-1.17 | $-2.15 | $-33.16 | $-23.74 |
| EPS (Diluted) | - | $-1.17 | $-2.15 | $-33.16 | $-23.74 |
| Basic Shares Outstanding | - | 19147726 | 11968665 | 1928172 | 656933 |
| Diluted Shares Outstanding | - | 19147726 | 11968665 | 1928172 | 656933 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Cosmos Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 715.7K | 315.1K | 3.8M | 20.7M | 286.5K |
| Short-term Investments | 46.2K | 21.1K | 20.1K | 14.9K | 11.5K |
| Accounts Receivable | 19.6M | 13.5M | 19.8M | 23.7M | 26.5M |
| Inventory | 5.8M | 4.4M | 4.8M | 3.5M | 3.1M |
| Other Current Assets | 6.5M | 4.9M | 6.3M | 4.9M | 6.3M |
| Total Current Assets | 38.4M | 25.5M | 36.6M | 56.4M | 39.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 600.6K | 709.8K | 1.2M | 1.1M | 211.1K |
| Goodwill | 7.6M | 7.8M | 7.7M | 756.6K | 535.5K |
| Intangible Assets | 7.5M | 7.7M | 7.6M | 657.2K | 436.1K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 4.6M | 2.9M | 1.1M | 391.6K | 1.8M |
| Total Non-Current Assets | 27.1M | 28.9M | 29.4M | 11.7M | 9.6M |
| Total Assets | 65.5M | 54.3M | 66.0M | 68.0M | 49.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 14.6M | 11.2M | 11.9M | 10.1M | 12.1M |
| Short-term Debt | 13.7M | 9.8M | 8.5M | 8.3M | 13.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 7.1M | 3.4M | 3.5M | 2.7M | 1.3M |
| Total Current Liabilities | 38.3M | 25.8M | 24.3M | 21.7M | 29.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 6.2M | 2.1M | 3.9M | 3.7M | 13.6M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 2.6M | 2.0M | 1.8M | 2.9M | 1.6M |
| Total Non-Current Liabilities | 8.8M | 4.0M | 5.6M | 6.6M | 15.1M |
| Total Liabilities | 47.1M | 29.8M | 30.0M | 28.4M | 45.0M |
| Equity | |||||
| Common Stock | 41.2K | 23.7K | 16.0K | 10.6K | 702 |
| Retained Earnings | -133.2M | -114.0M | -91.6M | -66.2M | -34.3M |
| Treasury Stock | 917.2K | 917.2K | 917.2K | 816.7K | 816.7K |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 18.4M | 24.5M | 36.0M | 39.7M | 4.4M |
| Key Metrics | |||||
| Total Debt | 20.0M | 11.8M | 12.4M | 12.0M | 27.1M |
| Working Capital | 116.4K | -296.2K | 12.3M | 34.6M | 9.9M |
Balance Sheet Composition
Cosmos Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -19.1M | -16.2M | -18.5M | -13.8M | -8.0M |
| Depreciation & Amortization | 1.4M | 1.2M | 614.4K | 188.9K | 449.7K |
| Stock-Based Compensation | 2.3M | 1.7M | 577.9K | 24.4K | 5.9M |
| Working Capital Changes | -429.7K | 2.6M | -6.2M | -5.4M | -4.0M |
| Operating Cash Flow | -12.5M | -10.4M | -23.8M | -16.3M | -5.3M |
| Investing Activities | |||||
| Capital Expenditures | -55.7K | -418.1K | -3.0M | -61.5K | -581.4K |
| Acquisitions | - | 0 | -5.2M | 0 | - |
| Investment Purchases | - | - | 0 | -2.6K | 0 |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -1.9M | 50.9K | -7.6M | 287.4K | -517.7K |
| Financing Activities | |||||
| Share Repurchases | - | 0 | -100.5K | 0 | -376.9K |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 11.2M | 865.6K | 1.1M | 487.1K | 591.5K |
| Debt Repayment | -28.6M | -26.3M | -21.3M | -40.4M | -25.7M |
| Financing Cash Flow | -12.6M | -24.3M | -10.4M | -2.6M | -16.8M |
| Free Cash Flow | -8.6M | -9.0M | -24.8M | -15.3M | -8.0M |
| Net Change in Cash | -27.1M | -34.7M | -41.8M | -18.7M | -22.6M |
Cash Flow Trend
Cosmos Health Key Financial Ratios
Valuation Ratios
Forward P/E
4.98
Price to Book
0.78
Price to Sales
0.27
PEG Ratio
4.98
Profitability Ratios
Profit Margin
-29.33%
Operating Margin
-57.07%
Return on Equity
-89.13%
Return on Assets
-17.26%
Financial Health
Current Ratio
1.00
Debt to Equity
108.39
Beta
4.46
Per Share Data
EPS (TTM)
$-0.63
Book Value per Share
$0.45
Revenue per Share
$2.16
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| COSM | 18.1M | - | 0.78 | -89.13% | -29.33% | 108.39 |
| McKesson | 103.2B | 24.33 | -1,040.14 | -194.51% | 1.09% | -88.23 |
| Cencora | 60.6B | 37.46 | 31.84 | 133.47% | 0.50% | 472.58 |
| Owens & Minor | 184.1M | - | - | -196.39% | -12.45% | -4.86 |
| Quipt Home Medical | 162.3M | 493.00 | 1.59 | -9.31% | -4.03% | 102.33 |
| Synergy CHC | 5.2M | 3.86 | - | 53.36% | -40.62% | -1.16 |
Financial data is updated regularly. All figures are in the company's reporting currency.





